Liver transplant in patients with primary sclerosing cholangitis: A retrospective cohort from Northeastern Brazil

Table 3 Clinical variables of patients with primary sclerosing cholangitis according to the presence/absence of inflammatory bowel disease

	Total1	IBD1 yes	IBD1 no	P value2
Total	26	18 (69.2%)	9 (30.8%)	0.440
Sex				0.692
Male	16 (59%)	6 (67%)	10 (56%)
Female	11 (41%)	3 (33%)	8 (44%)
Age	40 ± 13 (36)	38 ± 15 (34)	35 ± 14 (32)
Ulcerative colitis	15 (83%)
Crohn’s disease	3 (17%)
AST/RV1c	6.1 ± 12.1 (2.9)	12.2 ± 19.8 (3.7)	2.8 ± 1.6 (2.6)	0.014
DM	5 (19%)	4 (44%)	1 (5.6%)	0.030
Esophageal varices				0.027
No	9 (36%)	0 (0%)	9 (50%)
Yes	16 (64%)	7 (100%)	9 (50%)
MELD	21.3 ± 5.5 (22.0)	24.6 ± 5.4 (23.0)	19.3 ± 4.7 (19.0)	0.033
Anastomosis
Roux-en-Y	8 (31%)	0 (0%)	8 (47%)	0.023
End-to-end	18 (69%)	9 (100%)	9 (53%)

¹Range; mean ± SD (median); n (%).

²Wilcoxon rank sum exact test; Wilcoxon rank sum test; Fisher’s exact test; Pearson’s χ² test.

AST: Aspartate transferase; DM: Diabetes mellitus; MELD: Model for end-stage liver disease; RV: reference value.